{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:57:37Z","timestamp":1776329857204,"version":"3.50.1"},"reference-count":49,"publisher":"Baskent University","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant."],"published-print":{"date-parts":[[2023,7,25]]},"DOI":"10.6002\/ect.2023.0110","type":"journal-issue","created":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T06:00:43Z","timestamp":1692252043000},"source":"Crossref","is-referenced-by-count":1,"title":[],"prefix":"10.6002","volume":"21","member":"4021","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Ruzzenente A, Bagante F, Bertuzzo F, et al. Liver resection for neuroendocrine tumor liver metastases within Milan criteria for liver transplantation. J Gastrointest Surg. 2019;23(1):93-100. doi:10.1007\/s11605-018-3973-9","DOI":"10.1007\/s11605-018-3973-9"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Tran CG, Sherman SK, Chandrasekharan C, Howe JR. Surgical management of neuroendocrine tumor liver metastases. Surg Oncol Clin N Am. 2021;30(1):39-55. doi:10.1016\/j.soc.2020.08.001","DOI":"10.1016\/j.soc.2020.08.001"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Riihimaki M, Hemminki A, Sundquist K, Sundquist J, Hemminki K. The epidemiology of metastases in neuroendocrine tumors. Int J Cancer. 2016;139(12):2679-2686. doi:10.1002\/ijc.30400","DOI":"10.1002\/ijc.30400"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Dasari A, Shen C, Halperin D, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3(10):1335-1342. doi:10.1001\/jamaoncol.2017.0589","DOI":"10.1001\/jamaoncol.2017.0589"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Frilling A, Rogiers X, Malago M, Liedke O, Kaun M, Broelsch CE. Liver transplantation in patients with liver metastases of neuroendocrine tumors. Transplant Proc. 1998;30(7):3298-3300. doi:10.1016\/s0041-1345(98)01037-9","DOI":"10.1016\/S0041-1345(98)01037-9"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Reddy SK, Clary BM. Neuroendocrine liver metastases. Surg Clin North Am. 2010;90(4):853-861. doi:10.1016\/j.suc.2010.04.016","DOI":"10.1016\/j.suc.2010.04.016"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Rossi RE, Burroughs AK, Caplin ME. Liver transplantation for unresectable neuroendocrine tumor liver metastases. Ann Surg Oncol. 2014;21(7):2398-2405. doi:10.1245\/s10434-014-3523-y","DOI":"10.1245\/s10434-014-3523-y"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Benevento A, Boni L, Frediani L, Ferrari A, Dionigi R. Result of liver resection as treatment for metastases from noncolorectal cancer. J Surg Oncol. 2000;74(1):24-29. doi:10.1002\/1096-9098(200005)74:1<24::AID-JSO6>3.0.CO;2-V","DOI":"10.1002\/1096-9098(200005)74:1<24::AID-JSO6>3.0.CO;2-V"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Norton JA, Warren RS, Kelly MG, Zuraek MB, Jensen RT. Aggressive surgery for metastatic liver neuroendocrine tumors. Surgery. 2003;134(6):1057-1063; discussion 1063-1055. doi:10.1016\/j.surg.2003.07.025","DOI":"10.1016\/j.surg.2003.07.025"},{"key":"ref9","unstructured":"10. McStay MK, Caplin ME. Carcinoid tumour. Minerva Med. 2002;93(5):389-401."},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Coppa J, Pulvirenti A, Schiavo M, et al. Resection versus transplantation for liver metastases from neuroendocrine tumors. Transplant Proc. 2001;33(1-2):1537-1539. doi:10.1016\/s0041-1345(00)02586-0","DOI":"10.1016\/S0041-1345(00)02586-0"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Blonski WC, Reddy KR, Shaked A, Siegelman E, Metz DC. Liver transplantation for metastatic neuroendocrine tumor: a case report and review of the literature. World J Gastroenterol. 2005;11(48):7676-7683. doi:10.3748\/wjg.v11.i48.7676","DOI":"10.3748\/wjg.v11.i48.7676"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Pavel M, Baudin E, Couvelard A, et al. ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary. Neuroendocrinology. 2012;95(2):157-176. doi:10.1159\/000335597","DOI":"10.1159\/000335597"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Gurusamy KS, Ramamoorthy R, Sharma D, Davidson BR. Liver resection versus other treatments for neuroendocrine tumours in patients with resectable liver metastases. Cochrane Database Syst Rev. 2009;2009(2):CD007060. doi:10.1002\/14651858.CD007060.pub2","DOI":"10.1002\/14651858.CD007060.pub2"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Chan MY, Ma KW, Chan A. Surgical management of neuroendocrine tumor-associated liver metastases: a review. Gland Surg. 2018;7(1):28-35. doi:10.21037\/gs.2017.11.16","DOI":"10.21037\/gs.2017.11.16"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Yuan CH, Wang J, Xiu DR, et al. Meta-analysis of liver resection versus nonsurgical treatments for pancreatic neuroendocrine tumors with liver metastases. Ann Surg Oncol. 2016;23(1):244-249. doi:10.1245\/s10434-015-4654-5","DOI":"10.1245\/s10434-015-4654-5"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Mayo SC, de Jong MC, Bloomston M, et al. Surgery versus intra-arterial therapy for neuroendocrine liver metastasis: a multicenter international analysis. Ann Surg Oncol. 2011;18(13):3657-3665. doi:10.1245\/s10434-011-1832-y","DOI":"10.1245\/s10434-011-1832-y"},{"key":"ref17","unstructured":"18. Makowka L, Tzakis AG, Mazzaferro V, et al. Transplantation of the liver for metastatic endocrine tumors of the intestine and pancreas. Surg Gynecol Obstet. 1989;168(2):107-111."},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Valvi D, Mei X, Gupta M, et al. Younger age is associated with improved survival in patients undergoing liver transplantation alone for metastatic neuroendocrine tumors. J Gastrointest Surg. 2021;25(6):1487-1493. doi:10.1007\/s11605-020-04708-1","DOI":"10.1007\/s11605-020-04708-1"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Korda D, Doros A, Piros L, et al. Liver transplant for metastatic neuroendocrine tumors: a single-center experience in Hungary. Transplant Proc. 2019;51(4):1251-1253. doi:10.1016\/j.transproceed.2019.04.010","DOI":"10.1016\/j.transproceed.2019.04.010"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Rosenau J, Bahr MJ, von Wasielewski R, et al. Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors. Transplantation. 2002;73(3):386-394. doi:10.1097\/00007890-200202150-00012","DOI":"10.1097\/00007890-200202150-00012"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. van Vilsteren FG, Baskin-Bey ES, Nagorney DM, et al. Liver transplantation for gastroenteropancreatic neuroendocrine cancers: defining selection criteria to improve survival. Liver Transpl. 2006;12(3):448-456. doi:10.1002\/lt.20702","DOI":"10.1002\/lt.20702"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Olausson M, Friman S, Herlenius G, et al. Orthotopic liver or multivisceral transplantation as treatment of metastatic neuroendocrine tumors. Liver Transpl. 2007;13(3):327-333. doi:10.1002\/lt.21056","DOI":"10.1002\/lt.21056"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24. Gedaly R, Daily MF, Davenport D, et al. Liver transplantation for the treatment of liver metastases from neuroendocrine tumors: an analysis of the UNOS database. Arch Surg. 2011;146(8):953-958. doi:10.1001\/archsurg.2011.186","DOI":"10.1001\/archsurg.2011.186"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Le Treut YP, Gregoire E, Klempnauer J, et al. Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: a 213-case European liver transplant registry study. Ann Surg. 2013;257(5):807-815. doi:10.1097\/SLA.0b013e31828ee17c","DOI":"10.1097\/SLA.0b013e31828ee17c"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26. Nobel YR, Goldberg DS. Variable use of model for end-stage liver disease exception points in patients with neuroendocrine tumors metastatic to the liver and its impact on patient outcomes. Transplantation. 2015;99(11):2341-2346. doi:10.1097\/TP.0000000000000723","DOI":"10.1097\/TP.0000000000000723"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27. Sher LS, Levi DM, Wecsler JS, et al. Liver transplantation for metastatic neuroendocrine tumors: outcomes and prognostic variables. J Surg Oncol. 2015;112(2):125-132. doi:10.1002\/jso.23973","DOI":"10.1002\/jso.23973"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"28. Mazzaferro V, Sposito C, Coppa J, et al. The long-term benefit of liver transplantation for hepatic metastases from neuroendocrine tumors. Am J Transplant. 2016;16(10):2892-2902. doi:10.1111\/ajt.13831","DOI":"10.1111\/ajt.13831"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29. Mathe Z, Tagkalos E, Paul A, et al. Liver transplantation for hepatic metastases of neuroendocrine pancreatic tumors: a survival-based analysis. Transplantation. 2011;91(5):575-582. doi:10.1097\/TP.0b013e3182081312","DOI":"10.1097\/TP.0b013e3182081312"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"30. Moris D, Tsilimigras DI, Ntanasis-Stathopoulos I, et al. Liver transplantation in patients with liver metastases from neuroendocrine tumors: a systematic review. Surgery. 2017;162(3):525-536. doi:10.1016\/j.surg.2017.05.006","DOI":"10.1016\/j.surg.2017.05.006"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"31. Fan ST, Le Treut YP, Mazzaferro V, et al. Liver transplantation for neuroendocrine tumour liver metastases. HPB (Oxford). 2015;17(1):23-28. doi:10.1111\/hpb.12308","DOI":"10.1111\/hpb.12308"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32. Duchateau NM, Canovai E, Vianna RM, et al. Combined liver-intestinal and multivisceral transplantation for neuroendocrine tumors extending beyond the liver: a systematic literature review. Transplant Rev (Orlando). 2022;36(1):100678. doi:10.1016\/j.trre.2022.100678","DOI":"10.1016\/j.trre.2022.100678"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"33. Pavel M, O'Toole D, Costa F, et al. ENETS Consensus Guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site. Neuroendocrinology. 2016;103(2):172-185. doi:10.1159\/000443167","DOI":"10.1159\/000443167"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"34. Mazzaferro V, Pulvirenti A, Coppa J. Neuroendocrine tumors metastatic to the liver: how to select patients for liver transplantation? J Hepatol. 2007;47(4):460-466. doi:10.1016\/j.jhep.2007.07.004","DOI":"10.1016\/j.jhep.2007.07.004"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"35. Yao JC, Hassan M, Phan A, et al. One hundred years after \"carcinoid\": epidemiology of and prognostic factors for neuroendocrine tumors in 35\u2009825 cases in the United States. J Clin Oncol. 2008;26(18):3063-3072. doi:10.1200\/JCO.2007.15.4377","DOI":"10.1200\/JCO.2007.15.4377"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"36. Le Treut YP, Gregoire E, Belghiti J, et al. Predictors of long-term survival after liver transplantation for metastatic endocrine tumors: an 85-case French multicentric report. Am J Transplant. 2008;8(6):1205-1213. doi:10.1111\/j.1600-6143.2008.02233.x","DOI":"10.1111\/j.1600-6143.2008.02233.x"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"37. Luchini C, Pelosi G, Scarpa A, et al. Neuroendocrine neoplasms of the biliary tree, liver and pancreas: a pathological approach. Pathologica. 2021;113(1):28-38. doi:10.32074\/1591-951X-231","DOI":"10.32074\/1591-951X-231"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"38. Michalopoulos N, Papavramidis TS, Karayannopoulou G, Pliakos I, Papavramidis ST, Kanellos I. Neuroendocrine tumors of extrahepatic biliary tract. Pathol Oncol Res. 2014;20(4):765-775. doi:10.1007\/s12253-014-9808-4","DOI":"10.1007\/s12253-014-9808-4"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"39. Takahashi K, Sasaki R, Oshiro Y, Fukunaga K, Oda T, Ohkohchi N. Well-differentiated endocrine carcinoma originating from the bile duct in association with a congenital choledochal cyst. Int Surg. 2012;97(4):315-320. doi:10.9738\/CC152.1","DOI":"10.9738\/CC152.1"},{"key":"ref39","unstructured":"40. Deylgat B, Vandenhaute S, De Wilde V, Van Den Berghe I, Feryn T. A rare cause of recurrent cholangitis: neuroendocrine tumour of the main bile duct: case report and review of literature. Translational Gastrointestinal Cancer. 2015;4(6):480-487."},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"41. Turrion VS, Salas C, Alvira LG, Jimenez M, Lucena JL, Ardaiz J. Carcinoid tumour of the common bile duct: an exceptional indication for liver transplantation. Transplant Proc. 2002;34(1):264-265. doi:10.1016\/s0041-1345(01)02754-3","DOI":"10.1016\/S0041-1345(01)02754-3"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"42. Hao L, Friedman AL, Navarro VJ, West B, Robert ME. Carcinoid tumor of the common bile duct producing gastrin and serotonin. J Clin Gastroenterol. 1996;23(1):63-65. doi:10.1097\/00004836-199607000-00018","DOI":"10.1097\/00004836-199607000-00018"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"43. Eshmuminov D, Studer DJ, Lopez Lopez V, et al. Controversy over liver transplantation or resection for neuroendocrine liver metastasis: tumor biology cuts the deal. Ann Surg. 2022;10.1097\/SLA.0000000000005663. doi:10.1097\/SLA.0000000000005663","DOI":"10.1097\/SLA.0000000000005663"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"44. Moradi AM, Entezari M, Safarpour MM, et al. Liver transplant for metastatic neuroendocrine tumors: a single-center report of 15 cases. Exp Clin Transplant. 2021;19(6):588-591. doi:10.6002\/ect.2019.0154","DOI":"10.6002\/ect.2019.0154"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"45. Nguyen NT, Harring TR, Goss JA, O'Mahony CA. Neuroendocrine liver metastases and orthotopic liver transplantation: the US experience. Int J Hepatol. 2011;2011:742890. doi:10.4061\/2011\/742890","DOI":"10.4061\/2011\/742890"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"46. Frilling A, Malago M, Weber F, et al. Liver transplantation for patients with metastatic endocrine tumors: single-center experience with 15 patients. Liver Transpl. 2006;12(7):1089-1096. doi:10.1002\/lt.20755","DOI":"10.1002\/lt.20755"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"47. Cahlin C, Friman S, Ahlman H, et al. Liver transplantation for metastatic neuroendocrine tumor disease. Transplant Proc. 2003;35(2):809-810. doi:10.1016\/s0041-1345(03)00079-4","DOI":"10.1016\/S0041-1345(03)00079-4"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"48. Lang H, Schlitt HJ, Schmidt H, et al. Total hepatectomy and liver transplantation for metastatic neuroendocrine tumors of the pancreas: a single center experience with ten patients. Langenbecks Arch Surg. 1999;384(4):370-377. doi:10.1007\/s004230050216","DOI":"10.1007\/s004230050216"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"49. Lehnert T. Liver transplantation for metastatic neuroendocrine carcinoma: an analysis of 103 patients. Transplantation. 1998;66(10):1307-1312. doi:10.1097\/00007890-199811270-00007","DOI":"10.1097\/00007890-199811270-00007"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T04:47:23Z","timestamp":1692334043000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ectrx.org\/detail\/archive\/2023\/21\/7\/0\/578\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,25]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7,25]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.2023.0110","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,25]]}}}